The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126114396 12611439 6 F 20160916 20160801 20160927 EXP JP-PFIZER INC-2016367117 PFIZER KAWAKAMI, T.. PERSISTENT INFECTION OF DRUG-RESISTANT INFLUENZA A VIRUS DURING CHEMOTHERAPY FOR MALIGNANT LYMPHOMA. INTERNAL MEDICINE. 2016;55(13):1807-1810 80.00 YR M Y 0.00000 20160927 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126114396 12611439 1 PS DOXORUBICIN HCL DOXORUBICIN HYDROCHLORIDE 1 Intravenous drip (6 CYCLES) SIX COURSES D 50467
126114396 12611439 2 SS GEMCITABINE HYDROCHLORIDE. GEMCITABINE HYDROCHLORIDE 1 Intravenous drip (2 CYCLES) TWO COURSES D 78339
126114396 12611439 3 SS CISPLATIN. CISPLATIN 1 Intravenous drip (2 CYCLES) TWO COURSES D 0
126114396 12611439 4 SS BENDAMUSTINE HYDROCHLORIDE. BENDAMUSTINE HYDROCHLORIDE 1 Intravenous drip UNK D 0
126114396 12611439 5 SS PREDNISOLONE. PREDNISOLONE 1 Oral (6 CYCLES) SIX COURSES D 0
126114396 12611439 6 SS PREDNISOLONE. PREDNISOLONE 1 Unknown 30 MG, DAILY D 0 30 MG
126114396 12611439 7 SS PREDNISOLONE. PREDNISOLONE 1 Oral EVERY OTHER DAY D 0 30 MG
126114396 12611439 8 SS PREDNISOLONE. PREDNISOLONE 1 Oral 20 MG, DAILY D 0 20 MG
126114396 12611439 9 SS RITUXIMAB RITUXIMAB 1 Intravenous drip (6 CYCLES) SIX COURSES D 0
126114396 12611439 10 SS RITUXIMAB RITUXIMAB 1 Intravenous drip (2 CYCLES, R-GDP) D 0
126114396 12611439 11 SS RITUXIMAB RITUXIMAB 1 Intravenous drip (2 CYCLES, R-GDP) D 0
126114396 12611439 12 SS RITUXIMAB RITUXIMAB 1 UNK D 0
126114396 12611439 13 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Intravenous drip (6 CYCLES) SIX COURSES D 0
126114396 12611439 14 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 EVERY OTHER DAY D 0 50 MG
126114396 12611439 15 SS CYCLOPHOSPHAMIDE. CYCLOPHOSPHAMIDE 1 Oral END OF FEBRUARY D 0 /wk
126114396 12611439 16 SS VINCRISTINE VINCRISTINE 1 Intravenous drip (6 CYCLES) SIX COURSES D 0
126114396 12611439 17 SS DEXAMETHASONE. DEXAMETHASONE 1 Oral (2 CYCLES) TWO COURSES D 0
126114396 12611439 18 SS ETOPOSIDE. ETOPOSIDE 1 Oral EVERY OTHER DAY D 0 50 MG
126114396 12611439 19 SS ETOPOSIDE. ETOPOSIDE 1 Oral UNK UNK, WEEKLY D 0 /wk
126114396 12611439 20 SS PROCARBAZINE PROCARBAZINE 1 Oral EVERY OTHER DAY D 0 50 MG
126114396 12611439 21 SS PROCARBAZINE PROCARBAZINE 1 Oral UNK UNK, WEEKLY D 0 /wk
126114396 12611439 22 SS OSELTAMIVIR OSELTAMIVIR 1 Oral 75 MILLIGRAM DAILY D 0 75 MG QD
126114396 12611439 23 SS OSELTAMIVIR OSELTAMIVIR 1 Oral 150 MILLIGRAM DAILY D 0 75 MG BID
126114396 12611439 24 SS OSELTAMIVIR OSELTAMIVIR 1 Oral 150 MILLIGRAM DAILY D 0 75 MG BID
126114396 12611439 25 SS PERAMIVIR PERAMIVIR 1 Intravenous (not otherwise specified) 300 MG, UNK D 0 300 MG
126114396 12611439 26 SS PERAMIVIR PERAMIVIR 1 Intravenous (not otherwise specified) 300 MG, UNK D 0 300 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126114396 12611439 1 Diffuse large B-cell lymphoma
126114396 12611439 2 Diffuse large B-cell lymphoma
126114396 12611439 3 Diffuse large B-cell lymphoma
126114396 12611439 4 Diffuse large B-cell lymphoma
126114396 12611439 5 Diffuse large B-cell lymphoma
126114396 12611439 9 Diffuse large B-cell lymphoma
126114396 12611439 13 Diffuse large B-cell lymphoma
126114396 12611439 16 Diffuse large B-cell lymphoma
126114396 12611439 17 Diffuse large B-cell lymphoma
126114396 12611439 18 Diffuse large B-cell lymphoma
126114396 12611439 20 Diffuse large B-cell lymphoma
126114396 12611439 22 Influenza
126114396 12611439 25 Influenza

Outcome of event

Event ID CASEID OUTC COD
126114396 12611439 DE
126114396 12611439 HO
126114396 12611439 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126114396 12611439 Influenza

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126114396 12611439 2 201409 201409 0
126114396 12611439 3 201409 201410 0
126114396 12611439 4 201411 201411 0
126114396 12611439 6 201412 0
126114396 12611439 7 201501 201501 0
126114396 12611439 8 201502 201504 0
126114396 12611439 10 201409 201410 0
126114396 12611439 11 201411 0
126114396 12611439 14 201501 0
126114396 12611439 15 201502 0
126114396 12611439 17 201409 201409 0
126114396 12611439 18 201501 201501 0
126114396 12611439 19 201502 0
126114396 12611439 20 201501 201501 0
126114396 12611439 21 201502 0
126114396 12611439 22 201501 0
126114396 12611439 23 201501 0
126114396 12611439 24 201502 0
126114396 12611439 25 201502 0
126114396 12611439 26 201502 0